Most Recent
Class action to be filed against Monash IVF over discarded embryos
Class Actions 2020-10-21 3:33 pm By Miklos Bolza

A Victoria Supreme Court class action will soon be filed against fertility clinic Monash IVF seeking compensation for women who allegedly had viable embryos discarded thanks to inaccurate genetic testing.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court issues mixed ruling in Merck Sharp & Dohme, Pfizer vaccine patent battle
Intellectual Property 2020-10-15 4:47 pm By Miklos Bolza

Pharmaceutical rivals Merck Sharp & Dohme and Pfizer have both suffered a blow in their efforts to patent a better pneumococcal vaccine, with a judge upholding both infringement and invalidity claims in the long-running case over the blockbuster Prevnar 13 vaccine.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Boehringer appeals win for Merck in parasite patent spat
Intellectual Property 2020-10-13 12:00 pm By Cat Fredenburgh

Pharmaceutical company Boehringer Ingelheim will take another crack at opposing a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ATO wins appeal in $60M tax dispute with Healius
Tax 2020-10-12 6:46 pm By Cat Fredenburgh

The Australian Taxation Office has secured a Full Federal Court victory in its $60 million tax battle with Healius, overturning a ruling that found the healthcare company could claw back a multi-million dollar tax refund.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Arrow drops opposition to Novartis patent for MS drug, despite win before IP Australia
Intellectual Property 2020-10-12 2:35 pm By Miklos Bolza

The Federal Court has upheld Novartis’ appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic drug maker Arrow Pharmaceuticals dropped its opposition to the patent despite prevailing before IP Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme drops lawsuit over Januvia patent
Intellectual Property 2020-10-09 2:25 pm By Cat Fredenburgh

Merck Sharp & Dohme has dropped a lawsuit brought against a unit of Indian generic manufacturer Lupin for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fifty horse owners saddle up for credibility attack at Zoetis class action trial
Class Actions 2020-10-07 3:54 pm By Miklos Bolza

Fifty horse owners may face cross-examination regarding adverse effects allegedly caused by Zoetis’ Hendra virus vaccine, with the company warning a four-week hearing scheduled to begin in March may be insufficient to deal with the horse owners’ evidence.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme settles trade mark spat with German drug company
Intellectual Property 2020-10-05 12:45 pm By Cat Fredenburgh

US drug company Merck Sharp & Dohme has settled trade mark litigation brought by German drug maker Merck KGaA alleging it violated a 1970 agreement by using the “Merck” mark in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Proportionality no basis to deny fees in $7M QRxPharma class action settlement, judge says
Class Actions 2020-09-29 3:12 pm By Miklos Bolza

A judge has approved a $7 million settlement in a class action against the directors of pharmaceutical company QRxPharma, only a third of which will go to group members, saying proportionality was not a basis for rejecting fees that were otherwise fair and reasonable.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge shuts down Boehringer challenge to Merck Sharp & Dohme parasite patent
Intellectual Property 2020-09-24 1:59 pm By Miklos Bolza

Pharmaceutical company Boehringer Ingelheim has failed in its Federal Court challenge to a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?